APO Research
Talk to an analyst

APO RESEARCH · REPORT

Islet Amyloid Polypeptide

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Islet Amyloid Polypeptide Industry Growth and Trends Forecast to 2032

19 December 202592 pages

Choose your research edition.

Industry ResearchIslet Amyloid Polypeptide Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Islet Amyloid Polypeptide Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Islet Amyloid Polypeptide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Islet Amyloid Polypeptide Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Islet Amyloid Polypeptide Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Islet Amyloid Polypeptide market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Islet Amyloid Polypeptide is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Islet Amyloid Polypeptide is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Islet Amyloid Polypeptide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Islet Amyloid Polypeptide include Adocia SAS, Neurimmune Holding AG, Nordic Bioscience A/S, Prothena Corp Plc, reMYND NV, Zealand Pharma AS, AstraZeneca Plc and Eli Lilly and Co, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Islet Amyloid Polypeptide market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Islet Amyloid Polypeptide market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Islet Amyloid Polypeptide market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Islet Amyloid Polypeptide.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Islet Amyloid Polypeptide market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Islet Amyloid Polypeptide Market by Company

Adocia SAS

Neurimmune Holding AG

Nordic Bioscience A/S

Prothena Corp Plc

reMYND NV

Zealand Pharma AS

AstraZeneca Plc

Eli Lilly and Co

Islet Amyloid Polypeptide Segment by Type

KBP-088

KBP-056

DACRA-089

DACRA-042

AC-253

Others

Islet Amyloid Polypeptide Segment by Application

Gastrointestinal

Musculoskeletal Disorders

Metabolic Disorders

Others

Islet Amyloid Polypeptide Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Islet Amyloid Polypeptide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Islet Amyloid Polypeptide and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Islet Amyloid Polypeptide.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Islet Amyloid Polypeptide manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Islet Amyloid Polypeptide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of KBP-088 Table 2. Major Company of KBP-056 Table 3. Major Company of DACRA-089 Table 4. Major Company of DACRA-042 Table 5. Major Company of AC-253 Table 6. Major Company of Others Table 7. Global Islet Amyloid Polypeptide Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 8. Global Islet Amyloid Polypeptide Sales by Type (2021-2026) & (K Units) Table 9. Global Islet Amyloid Polypeptide Sales Market Share in Volume by Type (2021-2026) Table 10. Global Islet Amyloid Polypeptide Sales by Type (2021-2026) & (US$ Million) Table 11. Global Islet Amyloid Polypeptide Sales Market Share in Value by Type (2021-2026) Table 12. Global Islet Amyloid Polypeptide Price by Type (2021-2026) & (US$/Unit) Table 13. Global Islet Amyloid Polypeptide Sales by Type (2027-2032) & (K Units) Table 14. Global Islet Amyloid Polypeptide Sales Market Share in Volume by Type (2027-2032) Table 15. Global Islet Amyloid Polypeptide Sales by Type (2027-2032) & (US$ Million) Table 16. Global Islet Amyloid Polypeptide Sales Market Share in Value by Type (2027-2032) Table 17. Global Islet Amyloid Polypeptide Price by Type (2027-2032) & (US$/Unit) Table 18. North America Islet Amyloid Polypeptide Sales by Type (2021-2026) & (K Units) Table 19. North America Islet Amyloid Polypeptide Sales by Type (2021-2026) & (US$ Million) Table 20. Europe Islet Amyloid Polypeptide Sales by Type (2021-2026) & (K Units) Table 21. Europe Islet Amyloid Polypeptide Sales by Type (2021-2026) & (US$ Million) Table 22. Asia-Pacific Islet Amyloid Polypeptide Sales by Type (2021-2026) & (K Units) Table 23. Asia-Pacific Islet Amyloid Polypeptide Sales by Type (2021-2026) & (US$ Million) Table 24. Latin America Islet Amyloid Polypeptide Sales by Type (2021-2026) & (K Units) Table 25. Latin America Islet Amyloid Polypeptide Sales by Type (2021-2026) & (US$ Million) Table 26. Middle East and Africa Islet Amyloid Polypeptide Sales by Type (2021-2026) & (K Units) Table 27. Middle East and Africa Islet Amyloid Polypeptide Sales by Type (2021-2026) & (US$ Million) Table 28. Islet Amyloid Polypeptide Industry Trends Table 29. Islet Amyloid Polypeptide Industry Drivers Table 30. Islet Amyloid Polypeptide Industry Opportunities and Challenges Table 31. Islet Amyloid Polypeptide Industry Restraints Table 32. Global Islet Amyloid Polypeptide Sales Revenue by Company (US$ Million) & (2021-2026) Table 33. Global Islet Amyloid Polypeptide Revenue Market Share by Company (2021-2026) Table 34. Global Islet Amyloid Polypeptide Sales by Company (2021-2026) & (K Units) Table 35. Global Islet Amyloid Polypeptide Sales Share by Company (2021-2026) Table 36. Global Islet Amyloid Polypeptide Market Price by Company (2021-2026) & (US$/Unit) Table 37. Global Islet Amyloid Polypeptide Industry Company Ranking, 2024 VS 2025 VS 2026 Table 38. Global Islet Amyloid Polypeptide Major Company Production Sites and Headquarters Table 39. Global Islet Amyloid Polypeptide Company, Product Type & Application Table 40. Global Islet Amyloid Polypeptide Company Establishment Date Table 41. Global Company Market Concentration Ratio (CR5 and HHI) Table 42. Global Islet Amyloid Polypeptide by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 43. Global Islet Amyloid Polypeptide Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 44. Global Islet Amyloid Polypeptide Sales by Region (2021-2026) & (K Units) Table 45. Global Islet Amyloid Polypeptide Sales Market Share in Volume by Region (2021-2026) Table 46. Global Islet Amyloid Polypeptide Sales by Region (2021-2026) & (US$ Million) Table 47. Global Islet Amyloid Polypeptide Sales Market Share in Value by Region (2021-2026) Table 48. Global Islet Amyloid Polypeptide Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 49. Global Islet Amyloid Polypeptide Sales by Region (2027-2032) & (K Units) Table 50. Global Islet Amyloid Polypeptide Sales Market Share in Volume by Region (2027-2032) Table 51. Global Islet Amyloid Polypeptide Sales by Region (2027-2032) & (US$ Million) Table 52. Global Islet Amyloid Polypeptide Sales Market Share in Value by Region (2027-2032) Table 53. Global Islet Amyloid Polypeptide Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 54. Global Islet Amyloid Polypeptide Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 55. Global Islet Amyloid Polypeptide Sales by Application (2021-2026) & (K Units) Table 56. Global Islet Amyloid Polypeptide Sales Market Share in Volume by Application (2021-2026) Table 57. Global Islet Amyloid Polypeptide Sales by Application (2021-2026) & (US$ Million) Table 58. Global Islet Amyloid Polypeptide Sales Market Share in Value by Application (2021-2026) Table 59. Global Islet Amyloid Polypeptide Price by Application (2021-2026) & (US$/Unit) Table 60. Global Islet Amyloid Polypeptide Sales by Application (2027-2032) & (K Units) Table 61. Global Islet Amyloid Polypeptide Sales Market Share in Volume by Application (2027-2032) Table 62. Global Islet Amyloid Polypeptide Sales by Application (2027-2032) & (US$ Million) Table 63. Global Islet Amyloid Polypeptide Sales Market Share in Value by Application (2027-2032) Table 64. Global Islet Amyloid Polypeptide Price by Application (2027-2032) & (US$/Unit) Table 65. North America Islet Amyloid Polypeptide Sales by Application (2021-2026) & (K Units) Table 66. North America Islet Amyloid Polypeptide Sales by Application (2021-2026) & (US$ Million) Table 67. Europe Islet Amyloid Polypeptide Sales by Application (2021-2026) & (K Units) Table 68. Europe Islet Amyloid Polypeptide Sales by Application (2021-2026) & (US$ Million) Table 69. Asia-Pacific Islet Amyloid Polypeptide Sales by Application (2021-2026) & (K Units) Table 70. Asia-Pacific Islet Amyloid Polypeptide Sales by Application (2021-2026) & (US$ Million) Table 71. Latin America Islet Amyloid Polypeptide Sales by Application (2021-2026) & (K Units) Table 72. Latin America Islet Amyloid Polypeptide Sales by Application (2021-2026) & (US$ Million) Table 73. Middle East and Africa Islet Amyloid Polypeptide Sales by Application (2021-2026) & (K Units) Table 74. Middle East and Africa Islet Amyloid Polypeptide Sales by Application (2021-2026) & (US$ Million) Table 75. Adocia SAS Company Information Table 76. Adocia SAS Business Overview Table 77. Adocia SAS Islet Amyloid Polypeptide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Adocia SAS Islet Amyloid Polypeptide Product Portfolio Table 79. Adocia SAS Recent Development Table 80. Neurimmune Holding AG Company Information Table 81. Neurimmune Holding AG Business Overview Table 82. Neurimmune Holding AG Islet Amyloid Polypeptide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Neurimmune Holding AG Islet Amyloid Polypeptide Product Portfolio Table 84. Neurimmune Holding AG Recent Development Table 85. Nordic Bioscience A/S Company Information Table 86. Nordic Bioscience A/S Business Overview Table 87. Nordic Bioscience A/S Islet Amyloid Polypeptide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Nordic Bioscience A/S Islet Amyloid Polypeptide Product Portfolio Table 89. Nordic Bioscience A/S Recent Development Table 90. Prothena Corp Plc Company Information Table 91. Prothena Corp Plc Business Overview Table 92. Prothena Corp Plc Islet Amyloid Polypeptide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Prothena Corp Plc Islet Amyloid Polypeptide Product Portfolio Table 94. Prothena Corp Plc Recent Development Table 95. reMYND NV Company Information Table 96. reMYND NV Business Overview Table 97. reMYND NV Islet Amyloid Polypeptide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. reMYND NV Islet Amyloid Polypeptide Product Portfolio Table 99. reMYND NV Recent Development Table 100. Zealand Pharma AS Company Information Table 101. Zealand Pharma AS Business Overview Table 102. Zealand Pharma AS Islet Amyloid Polypeptide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Zealand Pharma AS Islet Amyloid Polypeptide Product Portfolio Table 104. Zealand Pharma AS Recent Development Table 105. AstraZeneca Plc Company Information Table 106. AstraZeneca Plc Business Overview Table 107. AstraZeneca Plc Islet Amyloid Polypeptide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. AstraZeneca Plc Islet Amyloid Polypeptide Product Portfolio Table 109. AstraZeneca Plc Recent Development Table 110. Eli Lilly and Co Company Information Table 111. Eli Lilly and Co Business Overview Table 112. Eli Lilly and Co Islet Amyloid Polypeptide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Eli Lilly and Co Islet Amyloid Polypeptide Product Portfolio Table 114. Eli Lilly and Co Recent Development Table 115. North America Islet Amyloid Polypeptide Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 116. North America Islet Amyloid Polypeptide Sales by Country (2021-2026) & (K Units) Table 117. North America Islet Amyloid Polypeptide Sales Market Share by Country (2021-2026) Table 118. North America Islet Amyloid Polypeptide Sales Forecast by Country (2027-2032) & (K Units) Table 119. North America Islet Amyloid Polypeptide Sales Market Share Forecast by Country (2027-2032) Table 120. North America Islet Amyloid Polypeptide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 121. North America Islet Amyloid Polypeptide Market Size by Country (2021-2026) & (US$ Million) Table 122. North America Islet Amyloid Polypeptide Market Share by Country (2021-2026) Table 123. North America Islet Amyloid Polypeptide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 124. North America Islet Amyloid Polypeptide Market Share Forecast by Country (2027-2032) Table 125. Europe Islet Amyloid Polypeptide Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 126. Europe Islet Amyloid Polypeptide Sales by Country (2021-2026) & (K Units) Table 127. Europe Islet Amyloid Polypeptide Sales Market Share by Country (2021-2026) Table 128. Europe Islet Amyloid Polypeptide Sales Forecast by Country (2027-2032) & (K Units) Table 129. Europe Islet Amyloid Polypeptide Sales Market Share Forecast by Country (2027-2032) Table 130. Europe Islet Amyloid Polypeptide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 131. Europe Islet Amyloid Polypeptide Market Size by Country (2021-2026) & (US$ Million) Table 132. Europe Islet Amyloid Polypeptide Market Share by Country (2021-2026) Table 133. Europe Islet Amyloid Polypeptide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 134. Europe Islet Amyloid Polypeptide Market Share Forecast by Country (2027-2032) Table 135. Asia-Pacific Islet Amyloid Polypeptide Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 136. Asia-Pacific Islet Amyloid Polypeptide Sales by Country (2021-2026) & (K Units) Table 137. Asia-Pacific Islet Amyloid Polypeptide Sales Market Share by Country (2021-2026) Table 138. Asia-Pacific Islet Amyloid Polypeptide Sales Forecast by Country (2027-2032) & (K Units) Table 139. Asia-Pacific Islet Amyloid Polypeptide Sales Market Share Forecast by Country (2027-2032) Table 140. Asia-Pacific Islet Amyloid Polypeptide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 141. Asia-Pacific Islet Amyloid Polypeptide Market Size by Country (2021-2026) & (US$ Million) Table 142. Asia-Pacific Islet Amyloid Polypeptide Market Share by Country (2021-2026) Table 143. Asia-Pacific Islet Amyloid Polypeptide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 144. Asia-Pacific Islet Amyloid Polypeptide Market Share Forecast by Country (2027-2032) Table 145. Latin America Islet Amyloid Polypeptide Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 146. Latin America Islet Amyloid Polypeptide Sales by Country (2021-2026) & (K Units) Table 147. Latin America Islet Amyloid Polypeptide Sales Market Share by Country (2021-2026) Table 148. Latin America Islet Amyloid Polypeptide Sales Forecast by Country (2027-2032) & (K Units) Table 149. Latin America Islet Amyloid Polypeptide Sales Market Share Forecast by Country (2027-2032) Table 150. Latin America Islet Amyloid Polypeptide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 151. Latin America Islet Amyloid Polypeptide Market Size by Country (2021-2026) & (US$ Million) Table 152. Latin America Islet Amyloid Polypeptide Market Share by Country (2021-2026) Table 153. Latin America Islet Amyloid Polypeptide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 154. Latin America Islet Amyloid Polypeptide Market Share Forecast by Country (2027-2032) Table 155. Middle East and Africa Islet Amyloid Polypeptide Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 156. Middle East and Africa Islet Amyloid Polypeptide Sales by Country (2021-2026) & (K Units) Table 157. Middle East and Africa Islet Amyloid Polypeptide Sales Market Share by Country (2021-2026) Table 158. Middle East and Africa Islet Amyloid Polypeptide Sales Forecast by Country (2027-2032) & (K Units) Table 159. Middle East and Africa Islet Amyloid Polypeptide Sales Market Share Forecast by Country (2027-2032) Table 160. Middle East and Africa Islet Amyloid Polypeptide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 161. Middle East and Africa Islet Amyloid Polypeptide Market Size by Country (2021-2026) & (US$ Million) Table 162. Middle East and Africa Islet Amyloid Polypeptide Market Share by Country (2021-2026) Table 163. Middle East and Africa Islet Amyloid Polypeptide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 164. Middle East and Africa Islet Amyloid Polypeptide Market Share Forecast by Country (2027-2032) Table 165. Key Raw Materials Table 166. Raw Materials Key Suppliers Table 167. Islet Amyloid Polypeptide Distributors List Table 168. Islet Amyloid Polypeptide Customers List Table 169. Research Programs/Design for This Report Table 170. Authors List of This Report Table 171. Secondary Sources Table 172. Primary Sources List of Figures Figure 1. Islet Amyloid Polypeptide Image Figure 2. Global Islet Amyloid Polypeptide Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Islet Amyloid Polypeptide Market Size (2021-2032) & (US$ Million) Figure 4. Global Islet Amyloid Polypeptide Sales (2021-2032) & (K Units) Figure 5. KBP-088 Image Figure 6. Global KBP-088 Sales YoY Growth (2021-2032) & (K Units) Figure 7. KBP-056 Image Figure 8. Global KBP-056 Sales YoY Growth (2021-2032) & (K Units) Figure 9. DACRA-089 Image Figure 10. Global DACRA-089 Sales YoY Growth (2021-2032) & (K Units) Figure 11. DACRA-042 Image Figure 12. Global DACRA-042 Sales YoY Growth (2021-2032) & (K Units) Figure 13. AC-253 Image Figure 14. Global AC-253 Sales YoY Growth (2021-2032) & (K Units) Figure 15. Others Image Figure 16. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 17. Global Islet Amyloid Polypeptide Market Size Overview by Type (2021-2032) & (US$ Million) Figure 18. Global Islet Amyloid Polypeptide Market Share by Type 2025 VS 2032 Figure 19. North America Islet Amyloid Polypeptide Sales Market Share in Volume by Type in 2025 Figure 20. North America Islet Amyloid Polypeptide Sales Market Share in Value by Type in 2025 Figure 21. Europe Islet Amyloid Polypeptide Sales Market Share in Volume by Type in 2025 Figure 22. Europe Islet Amyloid Polypeptide Sales Market Share in Value by Type in 2025 Figure 23. Asia-Pacific Islet Amyloid Polypeptide Sales Market Share in Volume by Type in 2025 Figure 24. Asia-Pacific Islet Amyloid Polypeptide Sales Market Share in Value by Type in 2025 Figure 25. Latin America Islet Amyloid Polypeptide Sales Market Share in Volume by Type in 2025 Figure 26. Latin America Islet Amyloid Polypeptide Sales Market Share in Value by Type in 2025 Figure 27. Middle East and Africa Islet Amyloid Polypeptide Sales Market Share in Volume by Type in 2025 Figure 28. Middle East and Africa Islet Amyloid Polypeptide Sales Market Share in Value by Type in 2025 Figure 29. Global Top 5 and 10 Islet Amyloid Polypeptide Players Market Share by Revenue in 2025 Figure 30. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Gastrointestinal Image Figure 32. Global Gastrointestinal Sales YoY Growth (2021-2032) & (K Units) Figure 33. Musculoskeletal Disorders Image Figure 34. Global Musculoskeletal Disorders Sales YoY Growth (2021-2032) & (K Units) Figure 35. Metabolic Disorders Image Figure 36. Global Metabolic Disorders Sales YoY Growth (2021-2032) & (K Units) Figure 37. Others Image Figure 38. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 39. Global Islet Amyloid Polypeptide Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global Islet Amyloid Polypeptide Market Share by Application 2025 VS 2032 Figure 41. North America Islet Amyloid Polypeptide Sales Market Share in Volume by Application in 2025 Figure 42. North America Islet Amyloid Polypeptide Sales Market Share in Value by Application in 2025 Figure 43. Europe Islet Amyloid Polypeptide Sales Market Share in Volume by Application in 2025 Figure 44. Europe Islet Amyloid Polypeptide Sales Market Share in Value by Application in 2025 Figure 45. Asia-Pacific Islet Amyloid Polypeptide Sales Market Share in Volume by Application in 2025 Figure 46. Asia-Pacific Islet Amyloid Polypeptide Sales Market Share in Value by Application in 2025 Figure 47. Latin America Islet Amyloid Polypeptide Sales Market Share in Volume by Application in 2025 Figure 48. Latin America Islet Amyloid Polypeptide Sales Market Share in Value by Application in 2025 Figure 49. Middle East and Africa Islet Amyloid Polypeptide Sales Market Share in Volume by Application in 2025 Figure 50. Middle East and Africa Islet Amyloid Polypeptide Sales Market Share in Value by Application in 2025 Figure 51. North America Islet Amyloid Polypeptide Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. North America Islet Amyloid Polypeptide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. North America Islet Amyloid Polypeptide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. North America Islet Amyloid Polypeptide Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Islet Amyloid Polypeptide Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Europe Islet Amyloid Polypeptide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Islet Amyloid Polypeptide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Europe Islet Amyloid Polypeptide Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Islet Amyloid Polypeptide Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Asia-Pacific Islet Amyloid Polypeptide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Islet Amyloid Polypeptide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Asia-Pacific Islet Amyloid Polypeptide Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Islet Amyloid Polypeptide Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Latin America Islet Amyloid Polypeptide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Islet Amyloid Polypeptide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Latin America Islet Amyloid Polypeptide Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Islet Amyloid Polypeptide Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 68. Middle East and Africa Islet Amyloid Polypeptide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Islet Amyloid Polypeptide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Middle East and Africa Islet Amyloid Polypeptide Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. Islet Amyloid Polypeptide Value Chain Figure 72. Key Raw Materials Price Figure 73. Manufacturing Cost Structure Figure 74. Islet Amyloid Polypeptide Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • KBP-088
  • KBP-056
  • DACRA-089
  • DACRA-042
  • AC-253
  • Others
Applications
  • Gastrointestinal
  • Musculoskeletal Disorders
  • Metabolic Disorders
  • Others
Companies covered
  • Adocia SAS
  • Neurimmune Holding AG
  • Nordic Bioscience A/S
  • Prothena Corp Plc
  • reMYND NV
  • Zealand Pharma AS
  • AstraZeneca Plc
  • Eli Lilly and Co

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Islet Amyloid Polypeptide Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Islet Amyloid Polypeptide Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Islet Amyloid Polypeptide Market by Type
  6. 1.3.1 KBP-088
  7. 1.3.2 KBP-056
  8. 1.3.3 DACRA-089
  9. 1.3.4 DACRA-042
  10. 1.3.5 AC-253
  11. 1.3.6 Others
  12. 1.4 Global Islet Amyloid Polypeptide Market Size by Type
  13. 1.4.1 Global Islet Amyloid Polypeptide Market Size Overview by Type (2021-2032)
  14. 1.4.2 Global Islet Amyloid Polypeptide Historic Market Size Review by Type (2021-2026)
  15. 1.4.3 Global Islet Amyloid Polypeptide Forecasted Market Size by Type (2027-2032)
  16. 1.5 Key Regions Market Size by Type
  17. 1.5.1 North America Islet Amyloid Polypeptide Sales Breakdown by Type (2021-2026)
  18. 1.5.2 Europe Islet Amyloid Polypeptide Sales Breakdown by Type (2021-2026)
  19. 1.5.3 Asia-Pacific Islet Amyloid Polypeptide Sales Breakdown by Type (2021-2026)
  20. 1.5.4 South America Islet Amyloid Polypeptide Sales Breakdown by Type (2021-2026)
  21. 1.5.5 Middle East and Africa Islet Amyloid Polypeptide Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Islet Amyloid Polypeptide Industry Trends
  2. 2.2 Islet Amyloid Polypeptide Industry Drivers
  3. 2.3 Islet Amyloid Polypeptide Industry Opportunities and Challenges
  4. 2.4 Islet Amyloid Polypeptide Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Islet Amyloid Polypeptide Revenue (2021-2026)
  2. 3.2 Global Top Players by Islet Amyloid Polypeptide Sales (2021-2026)
  3. 3.3 Global Top Players by Islet Amyloid Polypeptide Price (2021-2026)
  4. 3.4 Global Islet Amyloid Polypeptide Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Islet Amyloid Polypeptide Major Company Production Sites & Headquarters
  6. 3.6 Global Islet Amyloid Polypeptide Company, Product Type & Application
  7. 3.7 Global Islet Amyloid Polypeptide Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Islet Amyloid Polypeptide Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Islet Amyloid Polypeptide Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Islet Amyloid Polypeptide Tier 1, Tier 2, and Tier 3
4 Islet Amyloid Polypeptide Regional Status and Outlook
  1. 4.1 Global Islet Amyloid Polypeptide Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Islet Amyloid Polypeptide Historic Market Size by Region
  3. 4.2.1 Global Islet Amyloid Polypeptide Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Islet Amyloid Polypeptide Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Islet Amyloid Polypeptide Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Islet Amyloid Polypeptide Forecasted Market Size by Region
  7. 4.3.1 Global Islet Amyloid Polypeptide Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Islet Amyloid Polypeptide Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Islet Amyloid Polypeptide Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Islet Amyloid Polypeptide by Application
  1. 5.1 Islet Amyloid Polypeptide Market by Application
  2. 5.1.1 Gastrointestinal
  3. 5.1.2 Musculoskeletal Disorders
  4. 5.1.3 Metabolic Disorders
  5. 5.1.4 Others
  6. 5.2 Global Islet Amyloid Polypeptide Market Size by Application
  7. 5.2.1 Global Islet Amyloid Polypeptide Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Islet Amyloid Polypeptide Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Islet Amyloid Polypeptide Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Islet Amyloid Polypeptide Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Islet Amyloid Polypeptide Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Islet Amyloid Polypeptide Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Islet Amyloid Polypeptide Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Islet Amyloid Polypeptide Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Adocia SAS
  2. 6.1.1 Adocia SAS Company Information
  3. 6.1.2 Adocia SAS Business Overview
  4. 6.1.3 Adocia SAS Islet Amyloid Polypeptide Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Adocia SAS Islet Amyloid Polypeptide Product Portfolio
  6. 6.1.5 Adocia SAS Recent Developments
  7. 6.2 Neurimmune Holding AG
  8. 6.2.1 Neurimmune Holding AG Company Information
  9. 6.2.2 Neurimmune Holding AG Business Overview
  10. 6.2.3 Neurimmune Holding AG Islet Amyloid Polypeptide Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Neurimmune Holding AG Islet Amyloid Polypeptide Product Portfolio
  12. 6.2.5 Neurimmune Holding AG Recent Developments
  13. 6.3 Nordic Bioscience A/S
  14. 6.3.1 Nordic Bioscience A/S Company Information
  15. 6.3.2 Nordic Bioscience A/S Business Overview
  16. 6.3.3 Nordic Bioscience A/S Islet Amyloid Polypeptide Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Nordic Bioscience A/S Islet Amyloid Polypeptide Product Portfolio
  18. 6.3.5 Nordic Bioscience A/S Recent Developments
  19. 6.4 Prothena Corp Plc
  20. 6.4.1 Prothena Corp Plc Company Information
  21. 6.4.2 Prothena Corp Plc Business Overview
  22. 6.4.3 Prothena Corp Plc Islet Amyloid Polypeptide Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Prothena Corp Plc Islet Amyloid Polypeptide Product Portfolio
  24. 6.4.5 Prothena Corp Plc Recent Developments
  25. 6.5 reMYND NV
  26. 6.5.1 reMYND NV Company Information
  27. 6.5.2 reMYND NV Business Overview
  28. 6.5.3 reMYND NV Islet Amyloid Polypeptide Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 reMYND NV Islet Amyloid Polypeptide Product Portfolio
  30. 6.5.5 reMYND NV Recent Developments
  31. 6.6 Zealand Pharma AS
  32. 6.6.1 Zealand Pharma AS Company Information
  33. 6.6.2 Zealand Pharma AS Business Overview
  34. 6.6.3 Zealand Pharma AS Islet Amyloid Polypeptide Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Zealand Pharma AS Islet Amyloid Polypeptide Product Portfolio
  36. 6.6.5 Zealand Pharma AS Recent Developments
  37. 6.7 AstraZeneca Plc
  38. 6.7.1 AstraZeneca Plc Company Information
  39. 6.7.2 AstraZeneca Plc Business Overview
  40. 6.7.3 AstraZeneca Plc Islet Amyloid Polypeptide Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 AstraZeneca Plc Islet Amyloid Polypeptide Product Portfolio
  42. 6.7.5 AstraZeneca Plc Recent Developments
  43. 6.8 Eli Lilly and Co
  44. 6.8.1 Eli Lilly and Co Company Information
  45. 6.8.2 Eli Lilly and Co Business Overview
  46. 6.8.3 Eli Lilly and Co Islet Amyloid Polypeptide Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Eli Lilly and Co Islet Amyloid Polypeptide Product Portfolio
  48. 6.8.5 Eli Lilly and Co Recent Developments
7 North America by Country
  1. 7.1 North America Islet Amyloid Polypeptide Sales by Country
  2. 7.1.1 North America Islet Amyloid Polypeptide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Islet Amyloid Polypeptide Sales by Country (2021-2026)
  4. 7.1.3 North America Islet Amyloid Polypeptide Sales Forecast by Country (2027-2032)
  5. 7.2 North America Islet Amyloid Polypeptide Market Size by Country
  6. 7.2.1 North America Islet Amyloid Polypeptide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Islet Amyloid Polypeptide Market Size by Country (2021-2026)
  8. 7.2.3 North America Islet Amyloid Polypeptide Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Islet Amyloid Polypeptide Sales by Country
  2. 8.1.1 Europe Islet Amyloid Polypeptide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Islet Amyloid Polypeptide Sales by Country (2021-2026)
  4. 8.1.3 Europe Islet Amyloid Polypeptide Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Islet Amyloid Polypeptide Market Size by Country
  6. 8.2.1 Europe Islet Amyloid Polypeptide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Islet Amyloid Polypeptide Market Size by Country (2021-2026)
  8. 8.2.3 Europe Islet Amyloid Polypeptide Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Islet Amyloid Polypeptide Sales by Country
  2. 9.1.1 Asia-Pacific Islet Amyloid Polypeptide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Islet Amyloid Polypeptide Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Islet Amyloid Polypeptide Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Islet Amyloid Polypeptide Market Size by Country
  6. 9.2.1 Asia-Pacific Islet Amyloid Polypeptide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Islet Amyloid Polypeptide Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Islet Amyloid Polypeptide Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Islet Amyloid Polypeptide Sales by Country
  2. 10.1.1 South America Islet Amyloid Polypeptide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Islet Amyloid Polypeptide Sales by Country (2021-2026)
  4. 10.1.3 South America Islet Amyloid Polypeptide Sales Forecast by Country (2027-2032)
  5. 10.2 South America Islet Amyloid Polypeptide Market Size by Country
  6. 10.2.1 South America Islet Amyloid Polypeptide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Islet Amyloid Polypeptide Market Size by Country (2021-2026)
  8. 10.2.3 South America Islet Amyloid Polypeptide Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Islet Amyloid Polypeptide Sales by Country
  2. 11.1.1 Middle East and Africa Islet Amyloid Polypeptide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Islet Amyloid Polypeptide Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Islet Amyloid Polypeptide Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Islet Amyloid Polypeptide Market Size by Country
  6. 11.2.1 Middle East and Africa Islet Amyloid Polypeptide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Islet Amyloid Polypeptide Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Islet Amyloid Polypeptide Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Islet Amyloid Polypeptide Value Chain Analysis
  2. 12.1.1 Islet Amyloid Polypeptide Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Islet Amyloid Polypeptide Production Mode & Process
  7. 12.2 Islet Amyloid Polypeptide Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Islet Amyloid Polypeptide Distributors
  10. 12.2.3 Islet Amyloid Polypeptide Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst